Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

87 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The risk of infections for multiple sclerosis and neuromyelitis optica spectrum disorder disease-modifying treatments: Eighth European Committee for Treatment and Research in Multiple Sclerosis Focused Workshop Review. April 2021.
Tur C, Dubessy AL, Otero-Romero S, Amato MP, Derfuss T, Di Pauli F, Iacobaeus E, Mycko M, Abboud H, Achiron A, Bellinvia A, Boyko A, Casanova JL, Clifford D, Dobson R, Farez MF, Filippi M, Fitzgerald KC, Fonderico M, Gouider R, Hacohen Y, Hellwig K, Hemmer B, Kappos L, Ladeira F, Lebrun-Frénay C, Louapre C, Magyari M, Mehling M, Oreja-Guevara C, Pandit L, Papeix C, Piehl F, Portaccio E, Ruiz-Camps I, Selmaj K, Simpson-Yap S, Siva A, Sorensen PS, Sormani MP, Trojano M, Vaknin-Dembinsky A, Vukusic S, Weinshenker B, Wiendl H, Winkelmann A, Zuluaga Rodas MI, Tintoré M, Stankoff B. Tur C, et al. Among authors: farez mf. Mult Scler. 2022 Aug;28(9):1424-1456. doi: 10.1177/13524585211069068. Epub 2022 Feb 23. Mult Scler. 2022. PMID: 35196927 Review.
Assessing robustness and generalization of a deep neural network for brain MS lesion segmentation on real-world data.
Chaves H, Serra MM, Shalom DE, Ananía P, Rueda F, Osa Sanz E, Stefanoff NI, Rodríguez Murúa S, Costa ME, Kitamura FC, Yañez P, Cejas C, Correale J, Ferrante E, Fernández Slezak D, Farez MF. Chaves H, et al. Among authors: farez mf. Eur Radiol. 2024 Mar;34(3):2024-2035. doi: 10.1007/s00330-023-10093-5. Epub 2023 Aug 31. Eur Radiol. 2024. PMID: 37650967
People with MS should consume a low-salt diet - YES.
Farez MF, Correale J. Farez MF, et al. Mult Scler. 2016 Dec;22(14):1777-1779. doi: 10.1177/1352458516660389. Epub 2016 Sep 8. Mult Scler. 2016. PMID: 27609134 No abstract available.
The role of infections in multiple sclerosis.
Marrodan M, Alessandro L, Farez MF, Correale J. Marrodan M, et al. Among authors: farez mf. Mult Scler. 2019 Jun;25(7):891-901. doi: 10.1177/1352458518823940. Epub 2019 Jan 14. Mult Scler. 2019. PMID: 30638421 Review.
Towards imaging criteria that best differentiate MS from NMOSD and MOGAD: Large multi-ethnic population and different clinical scenarios.
Carnero Contentti E, Rojas JI, Criniti J, Lopez PA, Daccach Marques V, Soto de Castillo I, Tkachuk V, Marrodan M, Correale J, Farez MF, Kim HJ, Hyun JW, Messina S, Mariano R, Rocca MA, Cacciaguerra L, Filippi M, Palace J, Juryńczyk M. Carnero Contentti E, et al. Among authors: farez mf. Mult Scler Relat Disord. 2022 May;61:103778. doi: 10.1016/j.msard.2022.103778. Epub 2022 Mar 27. Mult Scler Relat Disord. 2022. PMID: 35452969
ECTRIMS/EAN consensus on vaccination in people with multiple sclerosis: Improving immunization strategies in the era of highly active immunotherapeutic drugs.
Otero-Romero S, Lebrun-Frénay C, Reyes S, Amato MP, Campins M, Farez M, Filippi M, Hacohen Y, Hemmer B, Juuti R, Magyari M, Oreja-Guevara C, Siva A, Vukusic S, Tintoré M. Otero-Romero S, et al. Mult Scler. 2023 Jul;29(8):904-925. doi: 10.1177/13524585231168043. Epub 2023 Jun 9. Mult Scler. 2023. PMID: 37293841 Free PMC article. Review.
European Committee for Treatment and Research in Multiple Sclerosis and European Academy of Neurology consensus on vaccination in people with multiple sclerosis: Improving immunization strategies in the era of highly active immunotherapeutic drugs.
Otero-Romero S, Lebrun-Frénay C, Reyes S, Amato MP, Campins M, Farez M, Filippi M, Hacohen Y, Hemmer B, Juuti R, Magyari M, Oreja-Guevara C, Siva A, Vukusic S, Tintoré M. Otero-Romero S, et al. Eur J Neurol. 2023 Aug;30(8):2144-2176. doi: 10.1111/ene.15809. Epub 2023 Jun 9. Eur J Neurol. 2023. PMID: 37293849
87 results